| Field | Specification |
|---|---|
| Mfr No | |
| Clonality | |
| Host | |
| Immunogen | A synthesized peptide derived from human IL26 was used as the immunogen for the IL26 antibody. |
| Isotype | |
| Product Type | |
| Purity | |
| Reactivity | |
| Storage | |
| Target | |
| UniProt # |
Overview
IL26 Antibody / Interleukin 26 is an antibody targeting IL26. Host: Rabbit. Monoclonal. Clone: 31I11. Format: Liquid. Applications: WB.
Key elements and design rationale
- Target: IL26.
- Immunogen: A synthesized peptide derived from human IL26 was used as the immunogen for the IL26 antibody..
- Species reactivity: Human.
- Conjugate: Unconjugated (no label listed).
Biological background (from provided description)
IL26 antibody detects interleukin 26, a cytokine belonging to the IL-10 family that regulates immune cell communication. IL26 is secreted by activated T cells and natural killer cells, exerting its effects through a receptor complex composed of IL20RA and IL10RB subunits.
Common research applications
- WB: relative abundance and band pattern assessment using appropriate controls.
Notes for experimental interpretation
- Account for isoforms, paralogs, and post-translational modifications when interpreting signal.
- Support specificity with biological controls (e.g., KO/KD where available) and technical controls (e.g., secondary-only/isotype).
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
